Aki Kadota

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The introduction of generic drugs is promoted from the perspective of medical economics. In this context, we need to understand not only the bioequivalence of generic drugs specified in "the Guidelines for Bioequivalence Studies of Generic Products", but also formulation properties to consider their effect on pharmacological therapy. We evaluated the(More)
  • 1